Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GRIP1 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | KIAA0895L | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | RBMS2 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
mRNA | CBX8 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | SYT1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | ZNF414 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | GMFG | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
mRNA | FBN3 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | DDHD1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | GPBP1L1 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |